Use of FT-IR Spectra and PCA to the Bulk Characterization of Cell Wall Residues of Fruits and Vegetables Along a Fraction Process
Thursday, May 16, 2013
The study has demonstrated that discrimination between the cell wall residues of fruits and vegetables is possible with the use of FT-IR spectra analysed using the PCA method.
Researchers Unearth New Clues About How Prostate Cancer Evolved
Thursday, May 16, 2013
With the help of a computational model, Broad researchers were able to reconstruct the genomes of prostate cancer cells.
Halo Pharma Announces Investment and Formal Collaboration with Altus
Thursday, May 16, 2013
Halo Pharma has taken a minority ownership position in, and established a formal collaboration with, Altus Formulation Inc.
Methane Levels Studied Across States
Thursday, May 16, 2013
A UC Santa Barbara scientist has found that methane emissions across large parts of the U.S. are higher than currently known.
Spectral Announces First Quarter 2013 Results
Thursday, May 16, 2013
Company's Phase III EUPHRATES trial enrolled by the end of 2014.
Nobel Prize Rockets Stem Cell Program to New Heights
Thursday, May 16, 2013
Shinya Yamanaka's Feat Brings fresh attention to promise of regeneration medicine.
Dilaforette - Phase II Study with Sevuparin for the Treatment of Severe Malaria Initiated
Thursday, May 16, 2013
Company gets approval from the regulatory authority to start Phase II trial in India.
Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients
Thursday, May 16, 2013
In addition, a second Phase 2 trial of MPCs as a first-line biologic treatment for active RA is planned to commence in Europe in 1H 2013.
SYGNIS Licenses Amplification Buffer to QIAGEN
Thursday, May 16, 2013
This is the second agreement with QIAGEN within 9 months.
|
|
|
|
|
|
